Primary Job Title Co-Founder and President Primary Organization 
Brickell Biotech
Location Miami, Florida, United States Regions Greater Miami Area, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Mr. Hardy has successfully built an array of pharmaceutical companies. Prior to Brickell, Reginald was the co-founder and President of Concordia Pharmaceuticals, Inc. an oncology drug development company acquired by Kadmon Corporation in 2011. Mr. Hardy was co-founder and President of SANO Corporation, a pharmaceutical company focused on the
development of novel transdermal drug delivery systems that was acquired by Elan Corporation. Prior to SANO, Mr. Hardy served as the President of the generics group at IVAX Corporation. Reginald has also held various corporate roles with Hoechst-Roussel Pharmaceuticals, Inc. and Key Pharmaceuticals, Inc. Mr. Hardy earned his B.S. degree in Pharmacy from the University of North Carolina—Chapel Hill and M.B.A. from UNC-Greensboro.
Mr. Hardy is a Member of the University of North Carolina Innovation Circle whose mission is to create a robust environment for innovation and entrepreneurship throughout the university.
